Q3 EPS Estimate for Compass Therapeutics Reduced by Analyst
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Equities research analysts at Wedbush reduced their Q3 2025 earnings estimates for Compass Therapeutics in a research note issued on Tuesday, April 1st. Wedbush analyst R. Driscoll now expects that the company will earn ($0.13) per share for the quarter, down from their previous estimate of ($0.10). […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Equities research analysts at Wedbush reduced their Q3 2025 earnings estimates for Compass Therapeutics in a research note issued on Tuesday, April 1st. Wedbush analyst R. Driscoll now expects that the company will earn ($0.13) per share for the quarter, down from their previous estimate of ($0.10). […]
